World Journal of Methodology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 37

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1997)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

HTML

1355

Figures (1-4)

Tables (1-2)

Sum=1533

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

134

Sum=207

Oct 7, 2025 (publication date) through Feb 4, 2026

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Concepción-Zavaleta MJ, Fuentes-Mendoza JM, Gonzáles-Yovera JG, Ruvalcaba-Barbosa GY, Cura-Rodríguez LD, González-Rodríguez JS, Concepción-Urteaga LA, Pérez-Reyes AI, Quiroz-Aldave JE, Paz-Ibarra J. Efficacy and safety of anti-obesity drugs in metabolic dysfunction-associated steatotic liver disease: An updated review. World J Gastroenterol 2025; 31(37): 111435 [PMID: 41025003 DOI: 10.3748/wjg.v31.i37.111435]
URL:	https://www.wjgnet.com/2222-0682/full/v31/i37/111435.htm

For:

Concepción-Zavaleta MJ, Fuentes-Mendoza JM, Gonzáles-Yovera JG, Ruvalcaba-Barbosa GY, Cura-Rodríguez LD, González-Rodríguez JS, Concepción-Urteaga LA, Pérez-Reyes AI, Quiroz-Aldave JE, Paz-Ibarra J. Efficacy and safety of anti-obesity drugs in metabolic dysfunction-associated steatotic liver disease: An updated review. World J Gastroenterol 2025; 31(37): 111435 [PMID: 41025003 DOI: 10.3748/wjg.v31.i37.111435]

URL:

https://www.wjgnet.com/2222-0682/full/v31/i37/111435.htm

Number	Citing Articles
1	Liliane El Eid, Yusman Manchanda, Gregory Austin, Kieran Deane-Alder, Roxana-Maria Rujan, Zamara Mariam, Affiong I. Oqua, Matthew J. Belousoff, Jorge Bernardino de la Serna, Kyle W. Sloop, Guy A. Rutter, Alex Montoya, Dominic J. Withers, Steven J. Millership, Karim Bouzakri, Ben Jones, Christopher A. Reynolds, Patrick M. Sexton, Denise Wootten, Giuseppe Deganutti, Alejandra Tomas. In vivo functional profiling and structural characterization of the human GLP1R A316T variant . Science Advances 2026; 12(6) doi: 10.1126/sciadv.adw0899
2	Yangzheng He, Jing Li, Zhigang Wen, Yong Sun, Liufeng Zheng, Hongyan Li, Zeyuan Deng. Human milk fat substitutes improve obesity-related NAFLD by enriching LPC 18:2 to activate hepatic GPR119–AMPK signaling. Journal of Advanced Research 2026; doi: 10.1016/j.jare.2026.01.083